A model incorporating combined RTIs and PIs therapy during early HIV-1 infection
From MaRDI portal
Publication:512691
DOI10.1016/J.MBS.2017.01.004zbMath1361.92039OpenAlexW2572536557WikidataQ36256125 ScholiaQ36256125MaRDI QIDQ512691
L. B. Suromo, Faraimunashe Chirove, Sutimin, Edy Soewono, Nuning Nuraini
Publication date: 27 February 2017
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.mbs.2017.01.004
Related Items (4)
A within-host drug resistance model with continuous state-dependent viral strains ⋮ Pre-exposure prophylaxis HIV/AIDS mathematical model with non classical isolation ⋮ An in-host HIV-1 infection model incorporating quiescent and activated \(\mathrm{CD}4^+\) T cells as well as CTL response ⋮ A stochastic model of HIV infection incorporating combined therapy of HAART driven by Lévy jumps
Cites Work
- Unnamed Item
- Unnamed Item
- A delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cells
- Dynamics of HIV infection of CD4\(^ +\) T cells
- Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay
- A chronic viral infection model with immune impairment
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- HIV dynamics: Modeling, data analysis, and optimal treatment protocols
- Models and estimation methods for clinical HIV-1 data
- A mathematical model for HIV treatment with time-varying antiretroviral therapy
- Analysis of Combined Langerhans and CD$4^+$ T Cells HIV Infection
- MODELING THE DRUG THERAPY FOR HIV INFECTION
- A Bayesian approach for estimating antiviral efficacy in HIV dynamic models
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- A Mathematical Model of Combined Drug Therapy of HIV Infection
- Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models
- A CTL-INCLUSIVE MATHEMATICAL MODEL FOR ANTIRETROVIRAL TREATMENT OF HIV INFECTION
This page was built for publication: A model incorporating combined RTIs and PIs therapy during early HIV-1 infection
